288
Participants
Start Date
March 27, 2024
Primary Completion Date
May 28, 2024
Study Completion Date
September 30, 2024
FDC of oxycodone 5 mg/ibuprofen 400 mg
receive one (1) experimental drug tablet (FCD of oxycodone 5mg/ibuprofen 400mg) + one (1) Tylex® placebo.
Tylex
receive one (1) Tylex® tablet (codeine 30 mg/paracetamol 500 mg) + one (1) FDC placebo tablet
Eurofarma Laboratorios S.A, São Paulo
Lead Sponsor
Eurofarma Laboratorios S.A.
INDUSTRY